Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017
Selective activation and targeting of autophagy in severe asthma. Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017
Characteristics, definition and phenotypes of severe asthma Source: Eur Respir Mon 2011; 51: 50-58 Year: 2011
Potential causes of lack of control in severe asthma Source: Eur Respir J 2007; 30: Suppl. 51, 614s Year: 2007
Is a degree of asthma therapy related to pulmonary function impairment? Source: Eur Respir J 2001; 18: Suppl. 33, 41s Year: 2001
PP223 – N-Acetyl cysteine rescues neonatal lethality caused by HRas/NRas deficiency by improving lung maturation and decreasing oxidative stress Source: ERS Lung Science Conference 2021 Year: 2021
Does inflammation decrease after recovery from severe exacerbation of COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Which functional alteration is mainly the cause in determining dyspnoeain COPD patients? Source: Eur Respir J 2004; 24: Suppl. 48, 288s Year: 2004
Characterisation of a model that mimics aspects of the hyper-inflammatory response observed during an acute exacerbation of COPD. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009
Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003
Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
The role of cathepsin S in the development of inflammation in patients with severe bronchial asthma Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Conclusion: clinical phenotypes of asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005
Are there any significant differences in the bacterial carrier of acute exacerbation of severe and very severe COPD according the degree of pulmonary functional impairment? Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
The role of TRAP exposure in the development and persistence of asthma and low lung function Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017
Muscle dysfunction as a systemic marker of risk for exacerbation of COPD patients: the Spanish "IMAGIM study" Source: Eur Respir J 2004; 24: Suppl. 48, 2s Year: 2004
Role of maternal phenotype in asthma development in children Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease Year: 2012
Genetic features of decrease in lung function in various forms of a chronic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005